ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 108 filers reported holding ARATANA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 93.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $268,000 | +37.4% | 45,942 | 0.0% | 0.00% | – |
Q2 2018 | $195,000 | -86.0% | 45,942 | -82.5% | 0.00% | -100.0% |
Q1 2017 | $1,390,000 | -45.6% | 262,338 | -26.3% | 0.00% | -66.7% |
Q4 2016 | $2,555,000 | +48.6% | 355,835 | +93.8% | 0.00% | +50.0% |
Q3 2016 | $1,719,000 | – | 183,617 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
March Altus Capital Management LP | 218,515 | $2,045,000 | 12.79% |
Broadfin Capital, LLC | 3,085,979 | $28,885,000 | 2.59% |
First Light Asset Management, LLC | 467,743 | $4,378,000 | 1.88% |
AWM Investment Company, Inc. | 1,005,000 | $9,407,000 | 1.72% |
MPM ASSET MANAGEMENT LLC | 250,000 | $2,340,000 | 0.77% |
Grandeur Peak Global Advisors, LLC | 394,450 | $3,692,000 | 0.72% |
TURNER INVESTMENTS LLC | 208,660 | $1,953,000 | 0.65% |
WALL STREET ASSOCIATES | 197,400 | $1,848,000 | 0.63% |
TFS CAPITAL LLC | 192,848 | $1,805,000 | 0.43% |
GENERAL AMERICAN INVESTORS CO INC | 412,101 | $3,857,000 | 0.39% |